Vaseem Palejwala
Technik-/Wissenschafts-/F&E-Leiter bei TIZIANA LIFE SCIENCES LTD
Aktive Positionen von Vaseem Palejwala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | - |
Karriereverlauf von Vaseem Palejwala
Ehemalige bekannte Positionen von Vaseem Palejwala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Corporate Officer/Principal | 01.01.2017 | 01.01.2019 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2012 | 01.01.2017 |
| Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | 01.01.2001 | 01.01.2012 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - |
Ausbildung von Vaseem Palejwala
| University of Baroda | Doctorate Degree |
| University of Mumbai | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Bermuda | 3 |
| Indien | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
| Sanofi-Synthelabo, Inc. | Health Technology |
- Börse
- Insiders
- Vaseem Palejwala
- Erfahrung
